Fredun Pharmaceuticals allots bonus shares in 2:1 ratio

Bonus issue of 1:1 or betterCorporate Actions View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.5%Reaction day

₹995.00

prior close

₹953.90

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.1%-1.4% vs market

Pharmaceuticals peers, median of 167sector-1.0%-1.5% vs sector

On the reaction day the stock moved 1.4 pts less than Nifty Microcap 250 and 1.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.4

15m

+0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.5-1.1-1.4-1.0-1.5

Next day

-4.7-0.5-4.3-0.3-4.5

-6.0-0.1-5.9-0.3-5.7

-11.0-1.3-9.7-1.5-9.5

-9.7-2.0-7.7-2.3-7.3

-10.6-1.6-9.0-1.9-8.7

-9.2-1.5-7.7-2.6-6.6

15d

+25.1+2.9+22.2-0.4+25.4

—+3.4—-0.4—

—+2.5—-0.2—

—-0.1—-4.2—

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Fredun Pharmaceuticals has allotted 1.10 crore bonus equity shares of face value Rs 10 each in a 2:1 ratio, meaning 2 new shares for every 1 existing share held. The record date was July 16, 2026. Post-allotment, paid-up share capital rises from 55.13 lakh shares (Rs 5.51 crore) to 1.65 crore shares (Rs 16.54 crore). The new shares rank pari-passu with existing equity shares including dividend rights.

Likely market impact

Share count triples but price adjusts downward proportionally. No change in overall shareholder value.